BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1329087)

  • 1. A point mutation in the MyoD basic domain imparts c-Myc-like properties.
    Van Antwerp ME; Chen DG; Chang C; Prochownik EV
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9010-4. PubMed ID: 1329087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis.
    Davis RL; Cheng PF; Lassar AB; Thayer M; Tapscott S; Weintraub H
    Princess Takamatsu Symp; 1989; 20():267-78. PubMed ID: 2562185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of myc proteins to canonical and noncanonical DNA sequences.
    Blackwell TK; Huang J; Ma A; Kretzner L; Alt FW; Eisenman RN; Weintraub H
    Mol Cell Biol; 1993 Sep; 13(9):5216-24. PubMed ID: 8395000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
    Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
    Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-specific transcriptional activation by MyoD.
    Weintraub H; Dwarki VJ; Verma I; Davis R; Hollenberg S; Snider L; Lassar A; Tapscott SJ
    Genes Dev; 1991 Aug; 5(8):1377-86. PubMed ID: 1651276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors.
    Anand G; Shapiro DN; Dickman PS; Prochownik EV
    J Clin Invest; 1994 Jan; 93(1):5-9. PubMed ID: 8282820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
    Kato GJ; Barrett J; Villa-Garcia M; Dang CV
    Mol Cell Biol; 1990 Nov; 10(11):5914-20. PubMed ID: 2233723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the c-MYC DNA-binding site.
    Halazonetis TD; Kandil AN
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6162-6. PubMed ID: 2068097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of cardiac MLC-2 promoter by MyoD in 10T1/2 fibroblast cells is independent of E-box requirement but depends upon new proteins that recognize MEF-2 site.
    Goswami SK; Siddiqui MA
    Cell Mol Biol Res; 1995; 41(3):199-205. PubMed ID: 8589760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of c-fos promoter by MyoD on muscle cell differentiation.
    Trouche D; Grigoriev M; Lenormand JL; Robin P; Leibovitch SA; Sassone-Corsi P; Harel-Bellan A
    Nature; 1993 May; 363(6424):79-82. PubMed ID: 8386804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly conserved asparagine in the basic domain of Myc is dispensable for DNA binding, transformation, and apoptosis.
    Bodis S; Hemesath T; Fisher DE
    Biochem Mol Med; 1997 Apr; 60(2):102-7. PubMed ID: 9169089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative pathway for gene regulation by Myc.
    Peukert K; Staller P; Schneider A; Carmichael G; Hänel F; Eilers M
    EMBO J; 1997 Sep; 16(18):5672-86. PubMed ID: 9312026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and suppression of the Myc transcriptional activation domain by p107.
    Gu W; Bhatia K; Magrath IT; Dang CV; Dalla-Favera R
    Science; 1994 Apr; 264(5156):251-4. PubMed ID: 8146655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paired MyoD-binding sites regulate myosin light chain gene expression.
    Wentworth BM; Donoghue M; Engert JC; Berglund EB; Rosenthal N
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1242-6. PubMed ID: 1847512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12.
    Davis RL; Weintraub H
    Science; 1992 May; 256(5059):1027-30. PubMed ID: 1317057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation domain of the muscle-specific gene-regulatory protein myf5.
    Braun T; Winter B; Bober E; Arnold HH
    Nature; 1990 Aug; 346(6285):663-5. PubMed ID: 2385294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer.
    Johnson JE; Birren SJ; Saito T; Anderson DJ
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3596-600. PubMed ID: 1314394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The c-myc protein represses the lambda 5 and TdT initiators.
    Mai S; Mårtensson IL
    Nucleic Acids Res; 1995 Jan; 23(1):1-9. PubMed ID: 7870572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.